First in Human Study to Evaluate AZD8205 in Patients With Advanced or Metastatic Solid Malignancies
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Biliary Tract Carcinoma|Ovarian Cancer|Endometrial Cancer
Interventions: DRUG: AZD8205
Sponsor: AstraZeneca